AIM Cancellation - Sinclair Pharma Plc (3970G)

TIDMSPH

RNS Number : 3970G

AIM

06 November 2018

NOTICE

06/11/2018 7:00am

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

At the request of the Company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 
SINCLAIR PHARMA PLC 
213800BNMD7JVMHW1772 
ORDINARY SHARES     (3385674) (GB0033856740)  SINR PHAR/PAR VTG FPD 0.01 
 OF 1P EACH, FULLY 
 PAID 
                    ------------------------  --------------------------

If you have any queries or require further information, please contact the company's nominated adviser on +44(0)20 7418 8900.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

AMOMMMGMVKZGRZM

(END) Dow Jones Newswires

November 06, 2018 02:00 ET (07:00 GMT)

Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Jan 2025 to Feb 2025